Program
Please note that this meeting will take place as an in-person event in San Diego and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference. Please see the registration page for details.
CME credit is available for in-person attendance for the designated sessions. On-demand presentations are not eligible for CME.
All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program in progress.
*-Short talk from proffered abstract
Wednesday, November 13
Thursday, November 14
- Plenary Session 1: Biology Behind Circulating Tumor Cells (CTCs)
- Plenary Session 2: Biology of Plasma Biomarkers
- Plenary Session 3: New Technologies for Liquid Biopsy Analyses
Friday, November 15
- Plenary Session 4: Early Detection of Primary Cancer and Relapse
- Plenary Session 5: Liquid Biopsy Detection and Monitoring of MRD
- Plenary Session 6: Monitoring Tumor Evolution in Cancer Patients
Saturday, November 16
- Plenary Session 7: Liquid Biopsy and Immunotherapy
- Plenary Session 8: Computational Science in Liquid Biopsy Analyses
REGISTRATION
3-7 P.M.
WELCOME AND Keynotes Lectures
6- 7:30 P.M.
- Ash A. Alizadeh, Stanford University, Stanford, California
- Clinical applications of liquid biopsy
Howard I. Scher, Memorial Sloan Kettering Cancer Center, New York, New York
OPENING RECEPTION
7:30-9 P.M.
CONTINENTAL BREAKFAST
7-8 A.M.
Plenary Session 1: Biology Behind Circulating Tumor Cells (CTCs)
8-10:05 a.m.
Session Chair: Catherine Alix-Panabières, University of Montpellier, Montpellier, France
- The biology of metastasis-competent CTCs in colon and breast cancer
Catherine Alix-Panabières, University of Montpellier, Montpellier, France - Sunitha Nagrath, University of Michigan, Ann Arbor, Michigan
- The biology of CTCs
Daniel A. Haber, Massachusetts General Hospital, Boston, Massachusetts
Short talks selected from proffered abstracts
Break
10:05-10:25 a.m.
Plenary Session 2: Biology of Plasma Biomarkers
10:25-12:30 p.m.
- The biology of extracellular vesicles
David C. Lyden, Weill Cornell Medicine, New York, New York - Viktor Adalsteinsson, Broad Institute of MIT and Harvard, Cambridge, Massachusetts
- The biology of non-coding RNAs: From basic science to patients
George A. Calin, The University of Texas MD Anderson Cancer Center, Houston, Texas
Short talks selected from proffered abstracts
Lunch on Own / Free Time
12:30-2:45 p.m.
Plenary Session 3: New Technologies for Liquid Biopsy Analyses
2:45-5:05 p.m.
Session Chair: Maximilian Diehn, Stanford University, Stanford, California
- CTCs
Shana O. Kelley, Northwestern University, Chicago, Illinois - Ultra-sensitive ctDNA technologies
Maximilian Diehn, Stanford University, Stanford, California - Heterogeneity of cancer-derived extracellular vesicles
Dolores Di Vizio, Cedars-Sinai Medical Center, Los Angeles, California - Circulating proteins
Samir M. Hanash, The University of Texas MD Anderson Cancer Center, Houston, Texas
Short talks selected from proffered abstracts
Poster Session A / Reception
5:15-7:45 p.m.
Evening off/ Dinner on Own
7:45 p.m.
CONTINENTAL BREAKFAST
7-8 A.M.
Plenary Session 4: Early Detection of Primary Cancer and Relapse
8-10:05 a.m.
- Jimmy Lin, Freenome, Inc., South San Francisco, California
- Detection and prevention of cancer
Lori Minasian, National Cancer Institute, Bethesda, Maryland - The CancerSEEK studies
Nickolas Papadopoulos, Johns Hopkins Medicine, Baltimore, Maryland
Short talks selected from proffered abstracts
BreaK
10:05-10:25 a.m.
Plenary Session 5: Liquid Biopsy Detection and Monitoring of MRD
10:25 a.m.- 12:15 p.m.
Session Chair: Luis A. Diaz, Jr., Memorial Sloan Kettering Cancer Center, New York, New York
- Early detection of MRD in cancer patients
Klaus Pantel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany - ctDNA based detection of MRD in colon cancer
Jeanne Tie, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia - Liquid biopsy in head and neck cancers
Scott V. Bratman, University of Toronto, Toronto, ON, Canada
Short talks selected from proffered abstracts
Lunch on Own/ Free Time
12:15-2:30 p.m.
Plenary Session 6: Monitoring Tumor Evolution in Cancer Patients
2:30-4:35 p.m.
Session Chair: Klaus Pantel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Cell-free DNA fragmentomics for cancer detection and monitoring
Jillian A. Phallen, Johns Hopkins University School of Medicine, Baltimore, Maryland - Jacqui A. Shaw, University of Leicester, Leicester, England
- Adam Widman, Memorial Sloan Kettering Cancer Center, New York, New York
Short talks selected from proffered abstracts
Poster Session B/ Reception
4:45- 7:15 p.m.
Evening off/ Dinner on Own
7:15 p.m.
CONTINENTAL BREAKFAST
7-8 A.M.
Plenary Session 7: Liquid Biopsy and Immunotherapy
8-10:05 a.m.
Session Chair: Luis A. Diaz, Jr., Memorial Sloan Kettering Cancer Center, New York, New York
- Albrecht Stenzinger, University Hospital Heidelberg, Heidelberg, Germany
- Liquid biopsies in pediatric solid tumors
Brian D. Crompton, Dana-Farber Cancer Institute, Boston, Massachusetts
Short talks selected from proffered abstracts
BREAK
10:05-10:25 A.M.
Plenary Session 8: Computational Science in Liquid Biopsy Analyses
10:25 a.m.- 12:30 p.m.
Session Chair: Núria Malats Riera, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
- Tommy Kaplan, The Hebrew University of Jerusalem, Jerusalem, Israel
- Methods for tumor phenotype classification from circulating tumor DNA
Gavin Ha, Fred Hutchinson Cancer Center, Seattle, Washington - Multimodal-data integration
Núria Malats Riera, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
Short talks selected from proffered abstracts